Target intelligence / Profile preview

Adenine-Thymine-rich duplex DNA (AT-rich DNA)

Target
AT-rich DNA
Molecular classification
Nucleic acid, DNA, Other
01

Overview

Adenine-Thymine-rich (AT-rich) duplex DNA refers to double-stranded DNA segments with a high proportion of A-T base pairs, which possess distinct structural and electrostatic properties compared to GC-rich regions (Zimmer & Wähnert, 1986). These sequences are frequently located in critical regulatory areas such as promoters (e.g., TATA boxes), origins of replication, and scaffold/matrix attachment regions (S/MARs), where they influence gene expression and chromosomal architecture (Nelson et al., 1987). The minor groove of AT-rich DNA is narrower and more electronegative, providing a unique binding pocket for small molecule ligands known as minor groove binders (MGBs) (Dervan, 2001). By binding to these regions, drugs can physically block the access of transcription factors and enzymes like polymerases, thereby inhibiting DNA replication and transcription. This mechanism is exploited in the development of antimicrobial, antiparasitic, and anticancer agents, such as Pentamidine and Diminazene (Wilson et al., 2008). For instance, minor groove binders can displace essential proteins from the DNA, leading to cell cycle arrest or apoptosis in rapidly dividing cells. In the context of infectious diseases, these agents often target the AT-rich kinetoplast DNA of parasites like Trypanosoma. However, achieving sufficient sequence specificity to avoid broad genotoxicity remains a significant therapeutic challenge in drug design. Despite these challenges, AT-rich DNA remains a foundational target for understanding DNA-ligand interactions and developing site-specific genomic tools.

Other names
AT-rich sequencesAT-rich regionsMinor groove of AT-rich DNAPoly(dA-dT) sequencesA-tracts
02

Mechanism of action

Minor groove binding that displaces transcription factors and inhibits DNA-dependent enzymes such as RNA polymerase and DNA polymerase (Zimmer & Wähnert, 1986; Dervan, 2001).

03

Biological functions

Gene regulationDNA replication initiationTranscription initiationChromatin organizationScaffold/Matrix attachmentOther
04

Disease associations

CancerInfectionParasitic diseaseViral infection
05

Safety considerations

GenotoxicityLack of sequence specificityCytotoxicityMutagenicity
06

Interacting drugs

Netropsin

6 more in the full profile.

07

Biomarkers

AT-content of target promotersHigh Mobility Group (HMG) protein expressionTopoisomerase II levels

Beyond the preview

Go deeper on Adenine-Thymine-rich duplex DNA (AT-rich DNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adenine-Thymine-rich duplex DNA (AT-rich DNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call